Have Google and Samsung just slain the flagship killers?

samsung galaxy s23 fe on marble counter
Galaxy S23 FE
Credit: Ryan Haines / Android Authority
Opinion post by
Robert Triggs

“Flagship killer” feels like a bit of a throwback these days, but the allure of a powerhouse handset without the premium price tag remains as appealing as ever. If you’re in the market for an affordable flagship phone, the new Google Pixel 8 and Samsung Galaxy S23 FE will undoubtedly be at the top of your shortlist.

Priced at $599 and $699, the two phones shave hundreds off the cost of entry compared to the premium Galaxy or iPhone series, yet they barely compromise the essential specifications. Both phones come equipped with great displays, solid camera setups, wireless charging, IP68 ratings, fast networking, and big batteries; essentially everything you’d want from a top-notch smartphone experience. That said, the phones trade down some aspects, such as older Gorilla Glass 5 protection and marginally weaker camera setups, to keep prices affordable compared to the top-end models. But those are certainly trade-offs we can live with.



from Android Authority https://ift.tt/9DxuQsN
via IFTTT

Comments

Post a Comment

Popular posts from this blog

6 investors discuss why AI is more than just a buzzword in biotech

As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. “Most of the companies we have seen have an AI component to support the discovery or development processes,” Francisco Dopazo, a general partner at Humboldt Fund told TechCrunch recently. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations. So to get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today. For Franck Lescure, a partner at Elaia Partners, in biotech, having an AI component isn’t an automatic deal closer. “We do not favor biotech startups with extant AI over those without: Bio-revolution is not only digital. Digital is one tool; the other major tool is the livin
Read more

Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures (Igor Bosilkovski/Forbes)

Image
Igor Bosilkovski / Forbes : Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures   —  Canadian collaborative conversational AI tool Voiceflow announced today that it has raised $20 million in a Series A round led by Felicis Ventures. from Techmeme https://ift.tt/3rFQ9St via IFTTT
Read more

Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics (Adam Rawnsley/Rolling Stone)

Image
Adam Rawnsley / Rolling Stone : Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics   —  Elon's mass firing of security staff and increased reliance on automation is going to make it easier for tyrants to shout … from Techmeme https://ift.tt/xQsF2ef via IFTTT
Read more